Tirzepatide Price Guide: How Much Does It Cost Without Insurance?

In October of 2026, Tirzepatide has a price range of $129 to $1,112 each month based on whether the medication is received through a brand-name prescription, a manufacturer’s savings program, or through a licensed compounding pharmacy. The price difference is incredible. A person who has commercial insurance and uses an Eli Lilly savings card may pay just $25 for Zepbound. On the other hand, a person without insurance who fills the prescription at a retail pharmacy pays over $1,000. This webpage details each price point with confirmed figures, checks out the two compounding pharmacies that we checked, and explains how to legally pay less.

What Tirzepatide Actually Costs in 2026

Three variables determine the answer: the product being filled, whether one has insurance, and the dispensing pharmacy. Eli Lilly sells Tirzepatide, which is branded in two ways. Mounjaro is for type 2 diabetes, while Zepbound is for chronic weight management. The two drugs are made with the same compound and in the same dosage, although the list prices and the insurance policies vary, too.

Brand-Name List Price (Mounjaro and Zepbound)

Zepbound comes with a wholesale acquisition cost (WAC) of $1,086 per month (verified October 2026, Eli Lilly investor relations). Mounjaro is listed at $1,112 per month (verified October 2026, Eli Lilly investor relations). WAC is the initial price before discounts, rebates, or insurance adjustments. Although a WAC is not always the price paid by patients at the pharmacy counter, it certainly serves as the beginning point for the puzzle of pricing.

Wegovy (semaglutide), the main competitor in the weight-loss injectable market, lists at $1,349 per month (verified October 2026, Novo Nordisk). That makes Zepbound roughly $263 cheaper per month at list price, before any discounts on either side. For a full comparison between the two drugs, see our tirzepatide vs Wegovy price breakdown.

Compounded Tirzepatide: A Legal Lower-Cost Route

State licensed 503A pharmacies prepare compounded tirzepatide with identical active ingredients. Instead of pre-filled pens, the compound is available in multi-dose vials and costs much less than the name brand. We verified that two providers deliver compounded tirzepatide via legal telehealth consultations. Compounded tirzepatide has not been approved by the FDA and can only be obtained through a prescription and medical consultation.

The following table compares the monthly costs of different suppliers such as compounded providers, self-pay vials offered by Zepbound, and the cost of Wegovy.

BiltRx’s $129 flat rate is the cheapest price available, but consultation and shipping fees are additional. Arc-1 offers everything at a single price. To compare prices annually and take all fees into account, please visit our cheapest tirzepatide calculator.

Three Legal Ways to Lower Your Tirzepatide Price

Purchasing the full WAC list price out of pocket is not advisable. The companies Eli Lilly and Novo Nordisk provide discounts and there are compounding pharmacies with their own route. Each option is different and comes with its own challenges.

Manufacturer Savings Cards and the $25 Copay

Eli Lilly offers savings cards for both Zepbound and Mounjaro. Patients with commercial insurance can pay as low as $25 per month (source: LillyDirect). The card covers the difference between your copay and the $25 floor, up to a maximum annual benefit. You must have commercial (employer or marketplace) insurance that covers the medication. Government insurance, including Medicare, Medicaid, and Tricare, does not qualify.

The savings card program is identical for Mounjaro. The card could cost as low as $25 per month depending on your commercial insurance (source: LillyDirect). However, the critical part is that there should be an actual coverage from your insurance company for the specified drug. Even though many plans do often cover "pills" used to treat diabetes, some commercial plans exclude the GLP-1s used for weight loss purposes only. If your insurance company does not cover the drug, the savings card becomes useless.

Self-Pay Vials Through LillyDirect

In 2024, Eli Lilly started selling Zepbound single-dose vials to patients without insurance via LillyDirect. This is the recognized medicine that has been approved by the FDA and is sold at a much lower price. The price depends on the dosage of the medication. The cost of Zepbound is $299 for 2.5 mg for one month, $399 for 5 mg for one month, and $449 for a drug prescribed for 45 days taking one strength of 7.5 mg up to 15 mg (source: LillyDirect). The insurance cannot be used for this option.

You can also find Mounjaro being offered by LillyDirect for $499 self-pay every month, as per source markup at LillyDirect. Mounjaro is more expensive than Zepbound in all the published price tiers, which can be important if your doctor is considering prescribing Zepbound for diabetes in an off-label manner, or Mounjaro for weight management. Be sure to consider both options.

Compounded Tirzepatide from Licensed Pharmacies

It is lawful to produce tirzepatide in compounding pharmacies as long as they work under the provisions of Section 503A of the Federal Food, Drug, and Cosmetic Act. The compound will be made according to the patient's prescription and is distributed in vials directly. Compounding tirzepatide is not approved by the FDA and requires a prescription from a doctor.

BiltRx price structure is $129 each month for compounded version of tirzepatide in any potency (verified on 22 October 2026, biltrx.com). There is additional fee for consultations and sending products. BiltRx provides also branded Mounjaro and Zepbound and prices them at $1,499 for patients who prefer to use FDA approved product (verified on 22 October 2026, biltrx.com).

According to Arc-1 pricing, the cost for tirzepatide is: $199.99 for a 2.5 mg dose, $249.99 for a 5 mg dose, and finally $399.99 for a 7.5 mg dose (verified on October 22, 2026; arc-1.co). The prices also include the cost of consultation and delivery. Also, they provide a mixture of glycine and vitamin B12. It has to be noted that Arc-1 is not available in California, Arkansas, Indiana, Minnesota, and South Carolina.

For an in-depth view of both companies, including the sources of their drugs and what to check before purchasing, refer to full tirzepatide cost guide.

Compounded Providers We Compared

We examined pricing, licensing, and pharmacy sourcing for the two company tirzepatide compounders mentioned below. Product sheets including the above information are shown here. The drug is not approved by the FDA and can only be used with a prescription obtained after consulting with a physician.

Price by Dose: How Escalation Changes Your Bill

The treatment with tirzepatide begins at a dosage of 2.5 mg and is gradually increased over the next months. Usually, patients reach a dosage of 5 mg within four to eight weeks, with some patients using even higher doses. The cost of dosage increase is determined by the price you are charged for each of the doses administered.

BiltRx has a static price of $129 for any dosage. In contrast, the monthly expense for Arc-1 rises from $199.99 to $399.99. Unlike those two medications, Zepbound self-pay vials have a more moderate increase in price from $299 at 2.5 mg to $449 at 7.5 mg or more.

Annual total costs decrease from an approximate $1,548 (in BiltRx, excluding consultation and shipping) to about $3,900 (in Arc-1) to around $4,700 (in Zepbound self-financing vials) by following a 12-month plan, from 2.5 mg initially and reaching 7.5 mg in the fourth month. Our cheapest tirzepatide page has done the complete math annually with every fee accounted for.

Insurance, Medicare, and the Coverage Gap

Coverage for tirzepatide is fragmented. Whether you pay $25 or $1,086 per month depends on your insurer, your diagnosis, and which product your physician prescribes.

Commercial Insurance with a Savings Card

If your commercial plan covers Zepbound or Mounjaro and you activate the Eli Lilly savings card, your copay drops to as low as $25 per month (source: LillyDirect). This is the cheapest legal way to get brand-name tirzepatide. The challenge is getting your plan to cover it in the first place. Many employers exclude weight-loss medications from their formulary. Mounjaro is more commonly covered because the diabetes indication has broader formulary acceptance. If your plan covers Mounjaro for diabetes but not Zepbound for weight loss, ask your physician whether a Mounjaro prescription is appropriate for your situation.

Medicare Part D and the GLP-1 Bridge

Medicare recipients have a unique issue: the savings cards given by the pharmaceutical companies are not acceptable for use with the state program. Eli Lilly does have a Medicare GLP-1 Bridge program which makes the cost of the same only $50 a month for eligible candidates (Source: LillyDirect). The criteria for eligibility are that one must have Part D plan which supports the drug. Medicare coverage for GLP-1 drugs has been on increase in the recent times, especially for the medications for diabetes.

No Insurance at All

Without any insurance, your options from cheapest to most expensive are:

1. Compounded tirzepatide from BiltRx: $129 per month plus consultation and shipping fees (verified 22 Oct 2026, biltrx.com)
2. Compounded tirzepatide from Arc-1: $199.99 to $399.99 per month, all-in (verified 22 Oct 2026, arc-1.co)
3. Zepbound self-pay vials through LillyDirect: $299 to $449 per month (source: LillyDirect)
4. Mounjaro self-pay through LillyDirect: $499 per month flat (source: LillyDirect)
5. Wegovy self-pay through NovoCare: $199 to $349 per month (source: NovoCare)

So compounded options are relatively inexpensive, but have not been approved by FDA. Zepbound self-pay vials have FDA approval and are much cheaper than retail prices according to WAC. Also, wegovy is a different drug (semaglutide versus tirzepatide), but can be considered in cases where tirzepatide does not fit your budget. All these options have been compared in our resource at tirzepatide cost breakdown page.

When a Tirzepatide Price Looks Too Low

If you come across the advertisement for tirzepatide for less than $100 without the need for consultation, that’s a bad sign. Legitimate, compounded tirzepatide must be prescribed by a licensed prescriber, filled at a licensed pharmacy, and shipped without breaks in the cold chain. All of these requirements incur some costs. Prices that are much lower than the minimum mandated by pharmacy economics indicate one of the three problems: either it’s a fake product that is not tirzepatide, the pharmacy is not properly licensed, or there’s no real medical oversight.

What are the specific signs to look out for? They include no need for a prescription, payment exclusively via cryptocurrency, shipment from a foreign country, absence of valid pharmacy license number, and wording referring to the product as "only for research purposes" or "not meant for human consumption." All of these indicate the likelihood of gray-market or fake peptide drugs. The FDA has issued several alerts against contaminated compounded semaglutide and tirzepatide issues. Saving $50 a month is not worth the danger of injecting risky substances.

Before ordering from any provider, verify their pharmacy license through your state board of pharmacy and check for LegitScript certification. Our compounded tirzepatide guide covers what to check before ordering.